Cancer Moonshot℠ - Obligations by Budget Mechanism
With over $190 million appropriated for Cancer Moonshot activities in fiscal year (FY) 2021, funding was allocated into four budget mechanisms: research grants, R&D contracts, intramural research, and research management and support, as shown in the chart below.
Similar to the institute’s annual appropriation, NCI reports Cancer Moonshot obligations by funding mechanism.
Type of Mechanism | Mechanism | Number | Amount1 |
---|---|---|---|
Research Project Grants (RPGs) | Competing | 7 | $1,818,651 |
Noncompeting | 58 | $60,399,839 | |
Administrative Supplements | 20 | $4,762,599 | |
Subtotal, without SBIR | 65 | $66,981,088 | |
SBIR/STTR Grants | 2 | $858,796 | |
Subtotal, RPGs | 67 | $67,839,884 | |
Centers | Cancer Centers Grants-P30s | 1 | $4,747,685 |
P50s | 7 | $8,382,195 | |
Cooperative Agreements-U54s/U41s | 15 | $13,244,735 | |
Subtotal, Centers | 23 | $26,374,615 | |
Other Research | Resource Grants-U24s/U2Cs | 11 |
$28,722,409 |
Subtotal, Other Research | 11 |
$28,722,409 |
|
Subtotal, Research Grants | 103 |
$122,936,908 |
|
Intramural Research | Program | 0 |
$49,648,875 |
Research Management & Support | RMS | 0 |
$0 |
R&D Contracts | R&D Contracts | 17 |
$27,393,003 |
SBIR/STTR Contracts | 7 |
$6,257,004 |
|
Subtotal, R&D Contracts | 24 |
$33,650,007 |
|
Total |
$206,235,789 |
||
1 Includes new obligations and recoveries from fiscal years 2017, 2018, 2019, and 2020 carryover accounts. |